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Introduction:  Cervical  locations  of malignant  peripheral  nerve  sheath  tumor  (MPNST)  are rare,  at  less
than 1%  of  malignant  tumors  of  this  region.
Case report:  A  53-year-old  woman  presented  with a lateral  cervical  swelling  involving  the  parotid  region.urgery
Histology  was in favor  of MPNST.  Adjuvant  radiotherapy  was  indicated  because  of the  inﬁltrating  nature
of  the  tumor.  At 2  years’  follow-up,  there  was no  recurrence.
Discussion: Clinical  diagnosis  is difﬁcult  in  cervical  MPNST.  Only  histology  with  immunohistochemistry
can establish  the  correct  diagnosis.  Treatment  requires  complete  surgical  resection  and  regular  clinical
follow-up.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Malignant peripheral nerve sheath tumor (MPNST), also known
s malignant schwannoma and formerly as neurogenic sarcoma
r neuroﬁbrosarcoma [1,2], is a peripheral nervous system tumor
eveloping in the nerve sheath [1,3,4], often from major nerve
runks and in the extremities [5]; head and neck locations are rare
4], at less than 10% [6].
The present report details the clinical, paraclinical and thera-
eutic aspects of MPNST.
. Case report
A 53-year-old woman with no particular history presented
ith left pretragal swelling of 1 year’s evolution with progressive
ncrease in volume. Physical examination found a painless, ﬁrm,
odular left pretragal swelling of 3 cm long-axis adhering to the
uperﬁcial plane. The covering skin was purplish. A painful left
ervical line prolonged the nodular swelling (Fig. 1). The cervical
ymph-node areas were uninvolved. Facial mobility was conserved.
ral examination was normal. Ultrasound found a centrally vas-
ularized macrolobular subcutaneous hypoechogenic formation
easuring 36 × 10 mm.  It extended into the parotid region, in
edial contact with the gland, and was then prolonged by a tubular
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879-7296/© 2014 Elsevier Masson SAS. All rights reserved.cervical formation with non-compressible hypoechogenic contents
suggestive of venous thrombosis. Cervical MRI  found a rounded
superﬁcial upper mandibular mass of low intensity on T1 and
high intensity on T2-weighted sequences, with strong gadolinium
uptake (Fig. 2), associated with an adjacent left cervical thrombotic
vein (Fig. 3). A diagnosis of parotid tumor was  suggested, indicating
surgical resection. Intra-operative exploration found a tumoral for-
mation in continuity with the superﬁcial cervical plexus branches
and inﬁltrating the parotid gland and covering skin. Frozen sec-
tion biopsy was  in favor of a malignant tumor of sarcomatous
aspect, with involvement of the surgical margins. Complementary
resection was performed, with free skin ﬂap reconstruction, with
healthy ﬁnal surgical margins. Final histologic analysis of the spec-
imen showed a WHO  stage-IV MPNST (Fig. 4). Postoperative course
was straightforward (Fig. 5). Thoraco-abdominal CT for extension
assessment found no further locations. Adjuvant radiation therapy
was prescribed. At 2 year’s follow-up, there had been no recurrence.
3. Discussion
MPNST [1,4] is of ectomesenchymatous origin [2]. Prevalence
is < 0.001% in the general population [1], and it accounts for < 5%
of soft-tissue sarcomas [1,4,7]. Incidence is higher in case of his-
tory of irradiation and in type-1 neuroﬁbromatosis (NF1) [2–5,8],
where incidence is 5% [4,5] and onset is earlier, in the 3rd decade of
life [8]. MPNST degenerates from well-established neuroﬁbromsas,
notably giant, multiple or extensive plexiform neuroﬁbroma [6–8].
Clinical diagnosis is difﬁcult due to rarity and a presentation that
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sig. 1. Pre-operative aspect, showing a mass in the parotid region, with skin inﬁl-
ration, prolonged by a lateral cervical line.
s often non-speciﬁc and may  mimic  adenopathy [3,4]. Symptoma-
ology is generally related to nerve compression [3]. This tumor
an manifest by pain [4] or rapid change in the neuroﬁbroma’s
haracteristics [8].
Imaging guides diagnosis and assesses extension [4,7]. MRI  is
he examination of choice [4,9], and generally ﬁnds an irregular
ultilobular lesion with heterogeneous contrast uptake [7].
Deﬁnitive diagnosis is histological, making ﬁne-needle aspira-
ion and biopsy especially useful [10]. In the present case, the
ig. 2. T2-weighted contrast-enhanced axial cervical MRI, showing mass with
trong uptake.Fig. 3. Coronal cervical MRI, showing cervical prolongation of the tumor.
parotid location suggested parotid origin, which is why we  opted
for histology following total resection. Diagnosis remains difﬁcult,
however, due to the great heterogeneity of the tumoral tissue and
similarity to other forms of sarcoma [5]. Immunohistochemistry is
highly contributive [7], with positive results for S100 protein [1,3,4]
and vimentin [7] speciﬁc to nerve cells.
Histologically, MPNST presents as well-differentiated, anaplas-
tic, epithelial or triton tumor [7]. The main differential diagnoses
are ﬁbrosarcoma, rhabdomyosarcoma, leiomyosarcoma, esthe-
sioneuroblastoma, poorly differentiated lymphoma and achromic
melanoma [7].
The treatment of choice is complete surgical resection [2,8].
Margins are usually checked in frozen sections, as in the present
case, both to conﬁrm diagnosis and to check resection quality.
Adjuvant therapies are not codiﬁed [2,8]. Histologically, MPNST is
radioresistant and chemoresistant [2]. Nevertheless, postoperative
radiotherapy has been reported as providing beneﬁt in high-grade
or large or deep MPNST or in case of margin invasion, as in the
Fig. 4. Histologic cross-section, positive for S100 protein (HE stain, × 200).
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[9] Prem S, Gangothria S, Reddyb KS, et al. Malignant peripheral nerve sheath
tumor of the mandible: a case report and review of literature. J Neurol ResFig. 5. Clinical aspect at 3 months’ follow-up.
resent case [4,9]. The contribution of chemotherapy is still under
ssessment [7].
MPNST is often aggressive [2], with a high rate of metastasis
nd local recurrence [1,2,8]. Dissemination is mainly hematogenic,
ith metastases to lung, bone and liver [4,5]. Regular prolonged,
asically clinical, surveillance is thus mandatory [5]. Prognosis
ssentially depends on resection quality, histologic stage, tumor
ize [3,4] and location [4,10], necrosis [7], and association with NF1
3]. Five-year survival is 20–50% [3,8].
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4. Conclusion
Diagnosis of MPNST is founded on a range of histologic and
notably immunohistochemical evidence. Surgery is the reference
attitude, aiming at resection with healthy margins to avoid recur-
rence.
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